
23 Feb 2023
Hikma Pharmaceuticals: Slight beat in FY22 and solid outlook for FY23
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals: Slight beat in FY22 and solid outlook for FY23
Hikma Pharmaceuticals Plc (HIK:LON) | 1,836 275.4 0.8% | Mkt Cap: 4,074m
- Published:
23 Feb 2023 -
Author:
Paul Cuddon | Kane Slutzkin -
Pages:
4 -